CMR Surgical Overview
Pro stress-test →CMR Surgical is a British medical device company based in Cambridge that produces a robot-assisted surgery system called Versius. As of March 2026, more than 45,000 patients worldwide have been treated using the Versius Surgical Robotic System, positioning CMR as the second most widely used robotic surgery platform globally. The company is executing a major U.S. market entry strategy following recent FDA clearances.
Strategic Profile
Pro stress-test →Founded in 2014, CMR Surgical is a private limited company backed by an international shareholder base. Versius is a modular and portable surgical robot designed to make it easier for hospitals and surgeons to give patients access to minimal access surgery, with compact design allowing it to move easily between departments and operating rooms with no dedicated OR required. CEO Massimiliano Colella delayed introducing the company's soft tissue surgery system in the U.S. by a year but says the improved robot now hitting the market was worth the wait.
Competitive Landscape
Pro stress-test →CMR positions itself as the second-most widely used robotic surgery platform globally behind leader Intuitive, which has treated over 20 million patients. The Versius Surgical Robotic System is a rival of the established Da Vinci Surgical System and claims to be more flexible and versatile with independent modular arms which are quick and easy to set up. Increased competition in surgical robotics will accelerate the market's overall growth and likely make robotic systems more affordable for many more hospitals globally.
Industry Context
CMR Surgical operates in Medical Devices / Surgical Robotics.
Key facts
Founded: 2014 · Headquarters: Cambridge, UK